Adaptimmune Therapeutics PLC
ADAPY- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001621227
No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Adaptimmune Therapeutics PLC insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Adaptimmune Therapeutics PLC, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Wood Gavin | Chief Financial Officer | 0 | Sep 3, 2025 | 0 |
| Bertrand William C JR | Chief Operating Officer | 986,352 | Aug 29, 2025 | 0 |
| Behbahani Ali | Director | 0Indirect | Aug 19, 2025 | 0 |
| EcoR1 Capital, LLC | 10% Owner | 100,371,882Indirect | Jul 30, 2025 | 0 |
| Rawcliffe Adrian | Chief Executive Officer | 44,327 | Feb 20, 2025 | 0 |
| Lunger John | Chief Patient Supply Officer | 7,510 | Feb 20, 2025 | 0 |
| Norry Elliot | Chief Medical Officer | 7,510 | Feb 20, 2025 | 0 |
| Piccina Cintia | Chief Commercial Officer | 18,421 | Feb 20, 2025 | 0 |
| Brewer Joanna Elizabeth | Chief Scientific Officer | – | Feb 20, 2025 | 0 |
| Mott David M | Director | – | Jul 1, 2024 | 0 |
| Hege Kristen | Director | – | Jul 1, 2024 | 0 |
| Allen Andrew R | Director | – | Jul 1, 2024 | 0 |
| Alleva Lawrence M | Director | – | Jul 1, 2024 | 0 |
| Menzel Garry E | Director | 75,056 | Jul 1, 2024 | 0 |
| Furey John | Director | – | Jul 1, 2024 | 0 |
| Hegde Priti | Director | – | Jul 1, 2024 | 0 |
| Tayton-Martin Helen Katrina | Chief Business & Strgy Officer | – | Jan 17, 2024 | 0 |
| Sigal Charles Elliott | Director | – | Jul 3, 2023 | 0 |
| Duncan Barbara Gayle | Director | – | Jul 1, 2022 | 0 |
| Noble James | Director | – | Jul 1, 2022 | 0 |
| Zaks Tal Zvi | Director | – | Jul 1, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 (view filing) | Jan 13-15 | 2 days | Norry ElliotChief Medical Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −22.2K | $0.5812 | −$12.9K | −61.7%13.8K after | 3 lots |
| Jan 15, 2025 (view filing) | Jan 15 | Same day | Piccina CintiaChief Commercial Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −13.0K | $0.57 | −$7.40K | −41.4%18.4K after | |
| Jan 15, 2025 (view filing) | Jan 13-15 | 2 days | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −59.6K | $0.5802 | −$34.6K | −58.9%41.6K after | 3 lots |
| Jan 17, 2025 (view filing) | Jan 17 | Same day | Rawcliffe AdrianChief Executive Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −30.6K | $0.58 | −$17.7K | −40.8%44.3K after | |
| Jan 17, 2025 (view filing) | Jan 17 | Same day | Bertrand William C JRChief Operating Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −5.58K | $0.58 | −$3.24K | −42.6%7.51K after | |
| Jan 17, 2025 (view filing) | Jan 17 | Same day | Lunger JohnChief Patient Supply Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −5.58K | $0.58 | −$3.24K | −42.6%7.51K after | |
| Jan 17, 2025 (view filing) | Jan 17 | Same day | Norry ElliotChief Medical Officer | SSaleAmerican Depositary Shares representing Ordinary Shares | −5.58K | $0.58 | −$3.24K | −42.6%7.51K after | |
| Jul 30, 2025 (view filing)6:20 PM ET | Jul 28-30 | 2 days | EcoR1 Capital, LLC10% Owner | SSale | −64.1M | $0.1076 | −$6.89M | −39.0%100.4M after | 3 lotsPrice outlier |
| Aug 19, 2025 (view filing)7:07 PM ET | Aug 15-18 | 4 days | Behbahani AliDirector | SSaleOrdinary Shares with a nominal value of 0.001 GBP per share | −19.5M | $0.0118 | −$229.2K | −100.0%0 after | 2 lots |
| Aug 29, 2025 (view filing)6:25 PM ET | Aug 28 | 1 day | Bertrand William C JRChief Operating Officer | SSaleOrdinary Shares with a nominal value of GBP0.001 per share | −207.0K | $0.0101 | −$2.09K | −17.3%986.4K after | |
| Sep 3, 2025 (view filing)5:00 PM ET | Sep 2 | 1 day | Wood GavinChief Financial Officer | SSaleOrdinary Shares with a nominal value of GBP0.001 per share | −96.0K | $0.0099 | −$950.4 | −100.0%0 after |